Across TCGA pan-cancer cohorts, ARMCX7P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of ARMCX7P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where ARMCX7P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ARMCX7P is over-expressed in tumor, although a few such as BLCA and PRAD show the opposite, repressed pattern.

THCA, BLCA, and PRAD are the cancer types where ARMCX7P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ARMCX7P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	+0.846	<.001	9	view →
BLCA	Male	III,IV	−0.310	.039	2	view →
PRAD	All	All	−0.126	.033	2	view →
PAAD	Male	All	−0.084	.003	2	view →
HNSC	All	All	+0.097	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: ARMCX7P RNA expression & survival · all ARMCX7P data types